General Session
Full session slides
NRG Town Hall
NCORP Sessions
NRG NCORP Town Hall
NRG Cancer Prevention & Control
NRG Cancer Care Delivery Research
Genitourinary Cancer Committee
Introduction
NRG GU Workshop
NRG-GU002
NRG-GU005
NRG-GU006
NRG-GU007
NRG-GU008
NRG-GU009
RTOG 3506
AE8143 - PROSPER RCC
ECOG NRG 8185
SWOG NRG 1806
Gastrointestinal Cancer Committee - Non-Colorectal
Non-CRC
Lung Cancer Committee
Investigator Resources
NRG-CC003
NRG-CC009
NRG-LU002
NRG-LU003
NRG-LU004
NRG-LU005
NRG-LU006
NRG-LU007
RTOG 1308
RTOG 3515
S1914
LungMAP
ALCHEMIST
Head and Neck Cancer Committee
Head and Neck Cancer Workshop
NRG-HN001
NRG-HN004
NRG-HN005
NRG-HN006
NRG-HN007
NRG-HN008
NRG-HN1936
NRG-HN1937
NRG-HN2001
NRG-HN2004
RTOG 1008
RTOG 1216
RTOG 3507
EA3132
EA3163, EA3161
Head and Neck Cancer Publications
Head and Neck Steering Committee
Head and Neck Cancer Biospecimen Access
Head and Neck Cancer Investigator Resources
NCI COVID-19 Overview
Brain Tumor Committee
Portfolio and Investigator Resources
NRG-BN2028
A Phase II Prospective Randomized Clinical Trial of Time, Dose, Fractionation, and Sequence of SRS and Immunotherapy in Melanoma Patients with Brain Metastases
Randomized Phase II/III Clinical and Translational Trial of Combination Checkpoint and IDO1 Inhibition with Chemoradiotherapy/Radiotherapy for Newly Diagnosed Glioblastoma
A Multi-site, Cooperative Group Study Establishing Quality and Feasibility of Multiparametric MRI for Radiation Tumor Targeting in Glioblastoma (Lead-in to a Randomized Phase III Trial)
Phase 1/2 Study of Mebendazole plus Radiation in Patients with Recurrent Meningioma Grade 2 or 3
PRIDE: Phase I/II study of Radiation /Temozolomide and Immunotherapy with Daratumumab to improve antitumor Efficacy in newly diagnosed Glioblastoma
Phase II Trial: Adenoviral Vectors Expressing FLT3L and HSV1-TK for Newly Diagnosed Resectable Malignant Glioma
EORTC 1634-BTG
Protocol Support Committee - CTN & CRA Workshop Educational Sessions-Thurs, July 16, 2020 Click here for slide sets/handouts for these presentations (login req'd)
Health Disparities Committee
HDC Overview Life Cycle of a Health Disparities Researcher
NRG New Investigators Educational Session (held Monday, July 20, 2020)
Webinar Slides
Webinar Recording Please skip to 4:15 of the recording where the webinar begins.
Program Book
Main Agenda
Session Flyers & Promotional Materials
NRG Oncology Townhall General Session CTN/CRA Workshop Educational Programs FORTE Workshop Digital Health Symposium NCORP Townhall
Other Materials and Information
FORTE Study Brochure
Gyn Concepts
Policies
Questions? Contact us at meeting-reg@nrgoncology.org if you have any questions or require more information.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.